Portrait of Yvonne G. Lin-Liu
ucsf logo

Yvonne G. Lin-Liu, MD, MS

Gynecologic Oncology • Gynecologic Surgical Oncology
Gynecologic Oncology Mission Bay
415-353-9600
Portrait of Yvonne G. Lin-Liu
Portrait of Yvonne G. Lin-Liu
ucsf logo

Yvonne G. Lin-Liu, MD, MS

Gynecologic Oncology • Gynecologic Surgical Oncology
Gynecologic Oncology Mission Bay
415-353-9600

On this page

About me

Dr. Yvonne G. Lin-Liu specializes in treating gynecologic cancers. She believes that knowledge is power, so she strives to help her patients understand the biology of their disease and all of their treatment options. Much of her practice focuses on serving women seeking second opinions and helping them make the best treatment decisions.

After earning a bachelor's degree in chemistry from the Massachusetts Institute of Technology, Lin-Liu completed a master of science degree in epidemiology at the Harvard T.H. Chan School of Public Health and then received a Fulbright fellowship to Taiwan. She earned her medical degree from the University of California, Irvine. She completed a residency in obstetrics and gynecology at Beth Israel Deaconess Medical Center and a fellowship in gynecologic oncology at the University of Texas MD Anderson Cancer Center.

Previously, Lin-Liu was a physician-scientist studying the impact of obesity on cellular stress, inflammation and endometrial cancer development. She joined Genentech in 2014 to advance the development of new cancer therapies for women around the world. Currently a medical director at Genentech in South San Francisco, she strongly believes that continuing to care for patients as a physician is key to improving treatment options for women with gynecologic cancers.

Lin-Liu has presented her research at multiple meetings and has published in prominent journals, including Cancer, the New England Journal of Medicine, Journal of the National Cancer Institute, Clinical Cancer Research and Oncogene. She is an active member of the Society of Gynecologic Oncology, Western Association of Gynecologic Oncologists, American Association for Cancer Research and American Society of Clinical Oncology. She volunteers on various society committees focused on professional development.

Education & training

Board certification

  • Gynecologic Oncology, American Board of OB/Gynecologic Oncology
  • Obstetrics & Gynecology, American Board of Obstetrics and Gynecology

Fellowship

  • Gynecologic Oncology, Univ of Texas MD Anderson Cancer Center

Residency

  • Obstetrics & Gynecology, Beth Israel Deaconess Medical Center GME

Internship

  • Obstetrics & Gynecology, Beth Israel Deaconess Medical Center GME

Degree

  • MD, University of California Irvine College of Medicine

My expertise

Locations

    Reviews

    Average rating

    4.9
    4.9 out of 5 Stars
    54 ratings
    About provider reviews

    Showing 1-6 of 24 reviews

    Sort by
    • 5 out of 5 Stars
      November 26, 2025

      Dr. Lin Liu is the BEST

    • 5 out of 5 Stars
      October 6, 2025

      I am so lucky to be under her care. Her team is also excellent.

    • 5 out of 5 Stars
      September 29, 2025

      I am grateful to Yvonne Lin Liu for her clear and concise communication and obvious care for me.

    • 5 out of 5 Stars
      September 26, 2025

      All my questions were answered to my satisfaction and a test was arranged as a precaution.

    • 5 out of 5 Stars
      September 26, 2025

      She was so helpful I had no problems

    • 5 out of 5 Stars
      August 5, 2025

      Dr. Lin-Liu always went above and beyond in making sure I understood my treatment and gave me agency in all decisions.

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.